5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow Rabeprazole Sodium: new trials by email Literature Review of Rabeprazole Sodium trials Research Report on Rabeprazole Sodium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants TNP-2198, Rabeprazole Sodium, Amoxicillin - Helicobacter Pylori Infection | Phase 2 | Completed | TenNor Therapeutics (Suzhou) Limited | 80 | 2022-06-26 | 2023-12-12 |
| A Study to Evaluate Preliminary Helicobacter Pylori Eradication After Multiple Doses of TNP-2198 Capsules Combined With Rabeprazole Sodium Enteric-coated Tablets, or Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules TNP-2198, Rabeprazole Sodium, Amoxicillin - Helicobacter Pylori Infection | Phase 1 / Phase 2 | Completed | TenNor Therapeutics (Suzhou) Limited | 40 | 2021-09-27 | 2023-11-22 |
| A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. Anaprazole Sodium, Rabeprazole sodium - Duodenal Ulcer，DU | Phase 2 | Completed | Sihuan Pharmaceutical Holdings Group Ltd. | 150 | 2018-10-09 | 2020-08-07 |
| To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis Z-215 10mg, Z-215 20mg, Z-215 Placebo - Esophagitis, Reflux | Phase 2 | Completed | Zeria Pharmaceutical | 503 | 2015-05-01 | 2017-07-02 |
| Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole rabeprazole sodium - Gastroesophageal Reflux Disease | Phase 2 | Completed | Eisai Inc. | 111 | 2005-08-01 | 2009-12-03 |
Esophagitis, Peptic (1) · Gastroesophageal Reflux (1)
TenNor Therapeutics (Suzhou) Limited (2) · Eisai Inc. (1) · Sihuan Pharmaceutical Holdings Group Ltd. (1) · Zeria Pharmaceutical (1)
China (3) · Japan (1) · United States (1)
Yufang Lu (1)